Terms: = Pancreatic cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Treatment
17 results:
1. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
2. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
[TBL] [Abstract] [Full Text] [Related]
3. Anticancer drug resistance: An update and perspective.
Nussinov R; Tsai CJ; Jang H
Drug Resist Updat; 2021 Dec; 59():100796. PubMed ID: 34953682
[TBL] [Abstract] [Full Text] [Related]
4. Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy.
Wang Y; Liu S; Yang Z; Algazi AP; Lomeli SH; Wang Y; Othus M; Hong A; Wang X; Randolph CE; Jones AM; Bosenberg MW; Byrum SD; Tackett AJ; Lopez H; Yates C; Solit DB; Ribas A; Piva M; Moriceau G; Lo RS
Cancer Cell; 2021 Oct; 39(10):1375-1387.e6. PubMed ID: 34416167
[TBL] [Abstract] [Full Text] [Related]
5. Oncogenic KRAS engages an RSK1/nf1 pathway to inhibit wild-type RAS signaling in pancreatic cancer.
Cheng DK; Oni TE; Thalappillil JS; Park Y; Ting HC; Alagesan B; Prasad NV; Addison K; Rivera KD; Pappin DJ; Van Aelst L; Tuveson DA
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34021083
[TBL] [Abstract] [Full Text] [Related]
6. Durable Response to PD-1 Blockade in a Patient With Metastatic pancreatic Undifferentiated Carcinoma With Osteoclast-Like Giant Cells.
Besaw RJ; Terra AR; Malvar GL; Chapman TR; Hertan LM; Schlechter BL
J Natl Compr Canc Netw; 2021 Mar; 19(3):247-252. PubMed ID: 33668025
[TBL] [Abstract] [Full Text] [Related]
7. Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Jan; 34(1):246-253. PubMed ID: 32870449
[TBL] [Abstract] [Full Text] [Related]
8. Screening guidelines and recommendations for patients at high risk of developing endocrine cancers.
Geurts JL; Strong EA; Wang TS; Evans DB; Clarke CN
J Surg Oncol; 2020 May; 121(6):975-983. PubMed ID: 32090344
[TBL] [Abstract] [Full Text] [Related]
9. Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
Patel H; Okamura R; Fanta P; Patel C; Lanman RB; Raymond VM; Kato S; Kurzrock R
J Hematol Oncol; 2019 Dec; 12(1):130. PubMed ID: 31801585
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine.
Ikeda M; Ioka T; Fukutomi A; Morizane C; Kasuga A; Takahashi H; Todaka A; Okusaka T; Creasy CL; Gorman S; Felitsky DJ; Kobayashi M; Zhang F; Furuse J
Cancer Sci; 2018 Jan; 109(1):215-224. PubMed ID: 29121415
[TBL] [Abstract] [Full Text] [Related]
11. MRI features of plexiform neurofibromas involving the liver and pancreas in children with neurofibromatosis type 1.
Delgado J; Jaramillo D; Ho-Fung V; Fisher MJ; Anupindi SA
Clin Radiol; 2014 Jun; 69(6):e280-4. PubMed ID: 24594377
[TBL] [Abstract] [Full Text] [Related]
12. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract] [Full Text] [Related]
13. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.
Jensen RT; Berna MJ; Bingham DB; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1807-43. PubMed ID: 18798544
[TBL] [Abstract] [Full Text] [Related]
14. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Toumpanakis CG; Caplin ME
Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
[TBL] [Abstract] [Full Text] [Related]
15. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract] [Full Text] [Related]
16. Signal therapy of human pancreatic cancer and nf1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract] [Full Text] [Related]
17. Sichuan pepper extracts block the PAK1/cyclin D1 pathway and the growth of nf1-deficient cancer xenograft in mice.
Hirokawa Y; Nheu T; Grimm K; Mautner V; Maeda S; Yoshida M; Komiyama K; Maruta H
Cancer Biol Ther; 2006 Mar; 5(3):305-9. PubMed ID: 16418572
[TBL] [Abstract] [Full Text] [Related]